United States · FDA National Drug Code directory
WEGOVY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0169-4517_f7b108b9-f276-4e32-84e7-e828ba145da5
- Product NDC
- 0169-4517
- Form
- INJECTION, SOLUTION
- Composition / generic term
- semaglutide
- Labeler
- Novo Nordisk Pharmaceutical Industries, LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20210605
- Source listing expiry
- 20271231
Source-listed ingredients
- SEMAGLUTIDE — 1.7 mg/.75mL
These values do not establish equivalence or a dose recommendation.
Packages
- 4 SYRINGE, PLASTIC in 1 CARTON (0169-4517-14) / .5 mL in 1 SYRINGE, PLASTIC (0169-4517-01) · 0169-4517-14
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →